Dilep Kumar Sigalapalli

Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data supporting this review are available from publicly accessible sources, including peer-reviewed publications and the ClinicalTrials.gov database (https://clinicaltrials.gov). No new data were generated in this study. References 1, , , and , “Inhibitors of Bruton's Tyrosine Kinase as Emerging Therapeutic Strategy in Autoimmune Diseases,” Autoimmunity Reviews 23 (2024): 103532.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance Sumaiya Kifayat,†a Vidyasrilekha Yele, †b Akram Ashames,*cd Dilep Kumar Sigalapalli,e Richie R. Bhandare, cd Afzal B. Shaik, f Venkatarathnam Nasipireddyg and Bharat Kumar Reddy Sanapalli *a Abstract In the pre-antibiotic era, common bacterial infections accounted for high mortality and morbidity.